Intas Pharmaceuticals
Teriparatide Injection Pen | Terifrac Solo - INTAS
Teriparatide Injection Pen | Terifrac Solo - INTAS
Couldn't load pickup availability
Advanced Subcutaneous Bone Health Care
When addressing severe osteoporosis and actively working to improve bone mineral density, healthcare providers and patients require treatments that are highly effective and easy to administer consistently. The Teriparatide Solution for Injection (commercially known as the Terifrac Solo pen) delivers a cutting-edge subcutaneous therapy designed to stimulate new bone formation and support long-term skeletal health. Manufactured by INTAS, a globally recognized leader in pharmaceutical innovation, this medication provides steady, reliable performance for individuals dedicated to strengthening their bones and reducing fracture risks.
Why Choose the Terifrac Solo Pen for Patient Care?
Patient adherence is critical in long-term bone health therapies. Instead of burdening patients with complicated vial-and-syringe preparations, the Terifrac Solo offers a highly intuitive, prefilled pen design. This multi-dose disposable device takes the guesswork out of daily administration, empowering patients to manage their health confidently and safely from home. Furthermore, INTAS’s rigorous manufacturing standards provide the built-in trust and reliability that clinics, hospitals, and pharmacies demand when stocking essential prescription medications.
Key Product Specifications & Clinical Benefits
Active Ingredient: Contains premium-grade Teriparatide, a synthetic portion of human parathyroid hormone clinically proven to effectively build new bone mass.
Precise Formulation: Each pen contains a carefully calibrated 600 mcg / 2.4 mL solution, ensuring accurate dose delivery with every injection.
Flexible Purchasing Options: Available as a single multi-dose disposable pen or in a convenient Pack of 3, allowing healthcare providers to seamlessly equip patients with extended supplies (such as a 3-month treatment plan) to prevent interrupted care.
Patient-Friendly Administration: Designed strictly for subcutaneous use, ensuring that daily self-administration is as minimally invasive and straightforward as possible.
Essential Storage & Usage Guidelines Maintaining the integrity of this peptide-based medication is critical for clinical efficacy. The pens must be stored according to standard pharmacological guidelines (typically refrigerated between 2°C to 8°C at all times; do not freeze). Patients must follow the enclosed instructions carefully to ensure the device is primed correctly and used safely.
Important Notice: Terifrac Solo is a prescription-only medication. It must be prescribed, titrated, and monitored strictly by a Registered Medical Practitioner. Read the enclosed package insert carefully for full indications, standard dosages, and administration safety.
Share
